| TTM
|
9/30/2025
|
9/30/2024
|
9/30/2023
|
9/30/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
4,596,753 | 4,032,966 | 3,960,827 | 4,210,305 | 3,811,368 |
|
Cost of Revenue
|
-4,135,277 | -3,626,452 | -3,582,297 | -3,815,751 | -3,464,139 |
|
Gross Profit
|
461,476 | 406,514 | 378,530 | 394,554 | 347,229 |
|
Selling, General and Administrative Expenses
|
-230,803 | -199,460 | -190,541 | -175,640 | -167,023 |
|
Operating Income/Expenses
|
-230,803 | -199,460 | -190,541 | -175,640 | -167,023 |
|
Total Operating Profit/Loss
|
230,673 | 207,054 | 187,989 | 218,914 | 180,206 |
| Total Net Finance Income/Expense
|
-8,670 | -7,683 | -25,016 | -28,404 | -14,553 |
| Irregular Income/Expenses
|
0 | -4,683 | -20,257 | -23,094 | -2,021 |
|
Other Income/Expense, Non-Operating
|
-6,980 | -6,670 | -13,184 | -6,403 | -5,329 |
|
Non-Operating Income/Expenses, Total
|
-15,650 | -19,036 | -58,457 | -57,901 | -21,903 |
|
Pretax Income
|
215,023 | 188,018 | 129,532 | 161,013 | 158,303 |
|
Provision for Income Tax
|
-29,610 | -15,133 | -17,717 | -21,919 | -20,060 |
|
Net Income from Continuing Operations
|
185,413 | 172,885 | 111,815 | 139,094 | 138,243 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
185,413 | 172,885 | 111,815 | 139,094 | 138,243 |
|
Net Income after Non-Controlling/Minority Interests
|
185,413 | 172,885 | 111,815 | 139,094 | 138,243 |
|
Net Income Available to Common Stockholders
|
185,413 | 172,885 | 111,815 | 139,094 | 138,243 |
|
Diluted Net Income Available to Common Stockholders
|
185,413 | 172,885 | 111,815 | 139,094 | 138,243 |
| Basic EPS
|
6.92 | 6.39 | 4.08 | 5.04 | 4.96 |
| Diluted EPS
|
6.77 | 6.26 | 4.01 | 4.95 | 4.86 |
|
Basic Weighted Average Shares Outstanding
|
26,783.75 | 27,038 | 27,397 | 27,582 | 27,862 |
|
Diluted Weighted Average Shares Outstanding
|
27,373.75 | 27,616 | 27,909 | 28,114 | 28,439 |
|
Reported Normalized Diluted EPS
|
8.27 | 7.43 | 5.72 | 5.70 | 4.92 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
223,693 | 195,701 | 154,548 | 189,417 | 172,856 |
|
EBITDA
|
300,333 | 273,493 | 232,395 | 259,175 | 235,545 |
|
Normalized EBITDA
|
344,955 | 308,444 | 287,702 | 303,569 | 260,902 |
|
Normalized Income
|
226,596 | 205,039.92 | 159,544.94 | 177,450.42 | 160,379.66 |
|
Total Unusual Items
|
44,622 | 34,951 | 55,307 | 44,394 | 25,357 |
|
Total Unusual Items Excluding Goodwill
|
44,622 | 34,951 | 55,307 | 44,394 | 25,357 |
|
Tax Effect of Unusual Items
|
6,144.72 | 2,796.08 | 7,577.06 | 6,037.58 | 3,220.34 |
9/30/2022 - 2/5/1986
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade